Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 31,182 shares at $4.49 ($140K) on 2022-11-16, disclosed to the SEC on 2022-11-18.
Open-market sale of $140k ATRA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.49 | 15,591 | $70K | 50.0% |
| 2 | $4.49 | 15,591 | $70K | 50.0% |
| Total | $4.49 avg | 31,182 | $140K | 100% |
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |